股本结构
单位：万股
| 公告日期 | 2025-11-06 | 2025-11-06 | 2025-08-05 | 2025-08-05 | 2025-04-22 | 2025-03-13 |
|---|---|---|---|---|---|---|
| 证券总股本 | 555.19 | 542.03 | 541.90 | 537.41 | 535.04 | 535.04 |
| 普通股本 | 555.19 | 542.03 | 541.90 | 537.41 | 535.04 | 535.04 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-11-05 | 2025-09-30 | 2025-08-04 | 2025-06-30 | 2025-04-07 | 2025-03-11 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-11-06 | 555.19 | 未披露 | 定期报告 | 2025-11-05 |
| 2025-11-06 | 542.03 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Vesting of restricted stock units
Common stock sold through ATM offering, net of costs
|
2025-09-30 |
| 2025-08-05 | 541.90 | 未披露 | 定期报告 | 2025-08-04 |
| 2025-08-05 | 537.41 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Common stock sold through ATM offering
|
2025-06-30 |
| 2025-04-22 | 535.04 | 未披露 | 定期报告 | 2025-04-07 |
| 2025-03-13 | 535.04 | 未披露 | 定期报告 | 2025-03-11 |
| 2024-04-23 | 534.79 | 未披露 | 定期报告 | 2024-04-14 |
| 2023-08-10 | 531.58 | 未披露 | 定期报告 | 2023-08-08 |
| 2023-08-10 | 523.48 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Redemption of Series B preferred stock
|
2023-06-30 |
| 2023-05-11 | 520.00 | 未披露 |
更多>>
On May 10, 2023, the Company’s Board of Directors approved a reverse stock split ratio of 1-for-17.
|
2023-05-12 |
| 2022-11-09 | 8851.08 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Option Exercises
|
2022-09-30 |
| 2022-08-08 | 8851.08 | 未披露 | 定期报告 | 2022-08-03 |
| 2022-08-08 | 8849.91 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Option Exercises
|
2022-06-30 |
| 2022-05-09 | 8849.91 | 未披露 | 定期报告 | 2022-05-06 |
| 2022-05-09 | 8849.89 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Option exercises
|
2022-03-31 |
| 2021-05-06 | 8829.07 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Option exercises
Common stock sold through equity offering
Common stock issued for warrant exercises
Common stock sold through ATM offering
|
2021-03-31 |
| 2021-03-11 | 8829.07 | 未披露 | 定期报告 | 2021-03-09 |
| 2021-01-28 | 7997.19 | 未披露 |
更多>>
1.Common stock offered by the company 14,285,714 shares.
2.The number of shares of common stock to be outstanding after this offering as reflected in the table above is based on the actual number of shares outstanding as of September 30, 2020, which was 65,686,150 shares.
|
2021-01-28 |
| 2021-03-11 | 7003.63 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Vesting of restricted stock units
Common stock sold through equity offering
Common stock issued for warrant exercises
Common stock sold through ATM offering
|
2020-12-31 |
| 2020-11-10 | 6568.62 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Common stock issued for warrant exercises
Common stock sold through ATM offering
|
2020-09-30 |
| 2020-08-21 | 6568.52 | 未披露 | 定期报告 | 2020-08-20 |
| 2020-08-06 | 6558.27 | 未披露 | 定期报告 | 2020-08-04 |
| 2020-08-06 | 6137.73 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Vesting of restricted stock units
Common stock issued for warrant exercises
|
2020-06-30 |
| 2020-05-07 | 4787.95 | 未披露 | 定期报告 | 2020-05-06 |
| 2020-05-07 | 4785.45 | 未披露 |
更多>>
From December 31, 2019 to March 12, 2020
Common stock sold through equity offering
Common stock issued for warrant exercises
|
2020-03-12 |
| 2020-02-27 | 4773.35 | 未披露 |
更多>>
Lipocine Inc. (NASDAQ:LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the closing of a registered direct offering of 10,084,034 Class A Units, each consisting of one share of its common stock and one half of a common warrant to purchase one share of its common stock, at a price of $0.595 per Class A Unit, for total gross proceeds to the Company of approximately $6 million, before deducting placement agent fees and other estimated offering expenses.
|
2020-02-27 |
| 2020-03-13 | 3764.95 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Common stock sold through equity offering
Pre-funded warrant exercises
Option exercises
Vesting of restricted stock units
Common stock sold through ATM offering
|
2019-12-31 |
| 2019-11-18 | 3547.78 | 未披露 | 定期报告 | 2019-11-18 |
| 2019-11-12 | 2540.20 | 未披露 | 定期报告 | 2019-11-11 |
| 2019-11-12 | 2502.78 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Common stock sold through ATM offering
Option exercises
|
2019-09-30 |
| 2019-08-07 | 2484.43 | 未披露 | 定期报告 | 2019-08-05 |
| 2019-08-07 | 2472.40 | 未披露 |
更多>>
From March 31, 2019 to June 30, 2019
Common stock sold through ATM offering
|
2019-06-30 |
| 2019-05-15 | 2457.50 | 未披露 | 定期报告 | 2019-05-06 |
| 2019-04-30 | 2458.07 | 未披露 | 定期报告 | 2019-04-15 |
| 2019-05-08 | 2457.50 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Common stock sold through ATM offering
|
2019-03-31 |
| 2019-04-30 | 2443.76 | 未披露 | 定期报告 | 2019-03-15 |
| 2019-03-06 | 2387.89 | 未披露 | 定期报告 | 2019-03-04 |
| 2019-03-06 | 2173.15 | 未披露 |
更多>>
From December 31, 2017 to December 31, 2018
Common stock sold through ATM offering
|
2018-12-31 |
| 2018-11-07 | 2146.40 | 未披露 | 定期报告 | 2018-11-05 |
| 2018-11-07 | 2133.43 | 未披露 | 定期报告 | 2018-09-30 |
| 2018-03-12 | 2126.45 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Option exercises
Vesting of restricted stock units
Common stock sold through ATM offering
|
2017-12-31 |
| 2017-11-08 | 2119.65 | 未披露 | 定期报告 | 2017-11-08 |
| 2017-11-08 | 2118.01 | 未披露 | 定期报告 | 2017-09-30 |
| 2017-08-07 | 2067.25 | 未披露 | 定期报告 | 2017-08-04 |
| 2017-08-07 | 2058.16 | 未披露 | 定期报告 | 2017-06-30 |
| 2017-04-28 | 1926.75 | 未披露 | 定期报告 | 2017-04-17 |
| 2017-05-08 | 1926.17 | 未披露 | 定期报告 | 2017-03-31 |
| 2017-04-28 | 1870.58 | 未披露 | 定期报告 | 2017-03-15 |
| 2017-03-06 | 1859.49 | 未披露 | 定期报告 | 2017-03-03 |
| 2017-03-06 | 1845.66 | 未披露 |
更多>>
From December 31, 2015 to December 31, 2016
Option exercises
Vesting of restricted stock awards
|
2016-12-31 |
| 2016-11-08 | 1826.09 | 未披露 | 定期报告 | 2016-11-08 |
| 2016-11-08 | 1825.32 | 未披露 | 定期报告 | 2016-09-30 |
| 2016-08-09 | 1825.89 | 未披露 | 定期报告 | 2016-08-09 |
| 2016-08-09 | 1825.22 | 未披露 | 定期报告 | 2016-06-30 |
| 2016-04-29 | 1825.89 | 未披露 | 定期报告 | 2016-04-15 |
| 2016-05-09 | 1825.12 | 未披露 | 定期报告 | 2016-03-31 |
| 2016-03-10 | 1825.35 | 未披露 | 定期报告 | 2016-03-09 |
| 2016-03-10 | 1824.47 | 未披露 |
更多>>
From December 31, 2014 to December 31, 2015
Option exercises
Vesting of restricted stock awards
Issuance of common stock in offering
|
2015-12-31 |
| 2015-11-12 | 1825.35 | 未披露 | 定期报告 | 2015-11-11 |
| 2015-11-12 | 1824.37 | 未披露 | 定期报告 | 2015-09-30 |
| 2015-08-11 | 1824.47 | 未披露 | 定期报告 | 2015-08-10 |
| 2015-08-11 | 1820.00 | 未披露 | 定期报告 | 2015-06-30 |
| 2015-05-07 | 1820.59 | 未披露 | 定期报告 | 2015-05-07 |
| 2015-04-20 | 1285.84 | 未披露 | 定期报告 | 2015-04-17 |
| 2015-05-07 | 1284.44 | 未披露 | 定期报告 | 2015-03-31 |
| 2015-03-11 | 1284.85 | 未披露 | 定期报告 | 2015-03-11 |
| 2015-03-11 | 1279.47 | 未披露 |
更多>>
from December 31, 2013 to December 31, 2014
Option exercises
Vesting of restricted stock awards
Vesting or restricted stock units
Purchase of treasury stock
|
2014-12-31 |
| 2014-11-10 | 1278.67 | 未披露 | 定期报告 | 2014-11-10 |
| 2014-11-10 | 1277.87 | 未披露 | 定期报告 | 2014-09-30 |
| 2014-10-01 | 1279.24 | 未披露 | 定期报告 | 2014-08-31 |
| 2014-08-13 | 1278.67 | 未披露 | 定期报告 | 2014-08-13 |
| 2014-08-13 | 1277.47 | 未披露 | 定期报告 | 2014-06-30 |
| 2014-04-29 | 1277.22 | 未披露 | 定期报告 | 2014-04-22 |
| 2014-05-13 | 1276.02 | 未披露 | 定期报告 | 2014-03-31 |
| 2014-03-31 | 1277.22 | 未披露 | 定期报告 | 2014-03-27 |
| 2014-03-31 | 1266.84 | 未披露 |
更多>>
from December 31, 2012 to December 31, 2013
Option exercises
Vesting of restricted stock awards
Repurchase and retirement of common stock
Issuance of common stock in private offering
Issuance of common stock in offering
Common stock issued in reverse merger
Issuance of common stock for termination of certain rights in stock purchase agreement
|
2013-12-31 |
| 2013-11-13 | 1105.64 | 未披露 | 定期报告 | 2013-11-12 |
| 2013-11-13 | 1095.26 | 未披露 | 定期报告 | 2013-09-30 |
From June 30, 2025 to September 30, 2025
Vesting of restricted stock units
Common stock sold through ATM offering, net of costs
From March 31, 2025 to June 30, 2025
Common stock sold through ATM offering
From March 31, 2023 to June 30, 2023
Redemption of Series B preferred stock
On May 10, 2023, the Company’s Board of Directors approved a reverse stock split ratio of 1-for-17.
From June 30, 2022 to September 30, 2022
Option Exercises
From March 31, 2022 to June 30, 2022
Option Exercises
From December 31, 2021 to March 31, 2022
Option exercises
From December 31, 2020 to March 31, 2021
Option exercises
Common stock sold through equity offering
Common stock issued for warrant exercises
Common stock sold through ATM offering
1.Common stock offered by the company 14,285,714 shares.
2.The number of shares of common stock to be outstanding after this offering as reflected in the table above is based on the actual number of shares outstanding as of September 30, 2020, which was 65,686,150 shares.
From December 31, 2019 to December 31, 2020
Vesting of restricted stock units
Common stock sold through equity offering
Common stock issued for warrant exercises
Common stock sold through ATM offering
From June 30, 2020 to September 30, 2020
Common stock issued for warrant exercises
Common stock sold through ATM offering
From March 31, 2020 to June 30, 2020
Vesting of restricted stock units
Common stock issued for warrant exercises
From December 31, 2019 to March 12, 2020
Common stock sold through equity offering
Common stock issued for warrant exercises
Lipocine Inc. (NASDAQ:LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the closing of a registered direct offering of 10,084,034 Class A Units, each consisting of one share of its common stock and one half of a common warrant to purchase one share of its common stock, at a price of $0.595 per Class A Unit, for total gross proceeds to the Company of approximately $6 million, before deducting placement agent fees and other estimated offering expenses.
From December 31, 2018 to December 31, 2019
Common stock sold through equity offering
Pre-funded warrant exercises
Option exercises
Vesting of restricted stock units
Common stock sold through ATM offering
from June 30, 2019 to September 30, 2019
Common stock sold through ATM offering
Option exercises
From March 31, 2019 to June 30, 2019
Common stock sold through ATM offering
from December 31, 2018 to March 31, 2019
Common stock sold through ATM offering
From December 31, 2017 to December 31, 2018
Common stock sold through ATM offering
from December 31, 2016 to December 31, 2017
Option exercises
Vesting of restricted stock units
Common stock sold through ATM offering
From December 31, 2015 to December 31, 2016
Option exercises
Vesting of restricted stock awards
From December 31, 2014 to December 31, 2015
Option exercises
Vesting of restricted stock awards
Issuance of common stock in offering
from December 31, 2013 to December 31, 2014
Option exercises
Vesting of restricted stock awards
Vesting or restricted stock units
Purchase of treasury stock
from December 31, 2012 to December 31, 2013
Option exercises
Vesting of restricted stock awards
Repurchase and retirement of common stock
Issuance of common stock in private offering
Issuance of common stock in offering
Common stock issued in reverse merger
Issuance of common stock for termination of certain rights in stock purchase agreement